Sequence LifeScience, Inc Receives IRB Approval for a Novel Matched Controls Clinical Trial Targeting Diabetic Foot Ulcers (DFUs)

Groundbreaking study aims to improve healing outcomes and reduce complications for patients with chronic wounds. The study will also reduce the number of patients being randomized into control groups by utilizing historic controls data documented in similar wound healing studies (matched controls)…
Sequence LifeScience, Inc Receives IRB Approval for a Novel Matched Controls Clinical Trial Targeting Diabetic Foot Ulcers (DFUs)

Sequence LifeScience, Inc Receives IRB Approval for a Novel Matched Controls Clinical Trial Targeting Diabetic Foot Ulcers (DFUs)

Groundbreaking study aims to improve healing outcomes and reduce complications for patients with chronic wounds. The study will also reduce the number of patients being randomized into control groups by utilizing historic controls data documented in similar wound healing studies (matched controls)…